Off-Label Policy: History And Legal Basis
This article was originally published in RPM Report
Executive Summary
Here is the “background” section from FDA’s March draft guidance on reprint distribution. The section includes more than 20 footnotes (omitted here) that reflect an effort by FDA to update and buttress the legal basis for the prohibition on off-label promotion.